Content
Cannabis Company Green Thumb Has Bounced Back From A Rocky Q4
Article By:
Lorimer Wilson
Read
Saturday, March 9, 2024 7:31 PM EDT
Green Thumb delivered a strong Q4, including record revenue of $278 million, but there's that little matter of its 93.5% drop in net income. But fear not - the low was hit last October and today it trades for double.
In this article: GTBIF
Q4 Results Of Cannabis Company Verano Holdings Were Down Across The Board
Article By:
Lorimer Wilson
Read
Friday, March 8, 2024 4:55 PM EDT
The company CEO is thankful for all that his team accomplished in 2023 and believes that Verano is well-positioned to continue capitalizing on growth opportunities.
In this article: VRNOF
Trulieve Cannabis Q4 Net Loss Increased By 32%
Article By:
Lorimer Wilson
Read
Friday, March 8, 2024 1:38 PM EDT
The CEO reports that "Q4 momentum was underpinned by improved consumer trends...[and, given the company's] strong cash generation and a clearly defined strategy, it is well positioned for the coming wave of meaningful growth catalysts."
In this article: TCNNF
Mapping Out America's Cannabis Dispensaries
Article By:
Tyler Durden
Read
Wednesday, March 6, 2024 11:32 PM EDT
American think-tank Pew Research released a new analysis that shows although marijuana is illegal at the federal level, many Americans live in states where cannabis is legal for medical or recreational use.
European Cannabis Q4 2023 Quarterly Update
Article By:
Michael Sassano
Read
Wednesday, March 6, 2024 6:20 PM EDT
Although Europe had a slow year along with most developed markets, the upbeat drums of new countries have invigorated the industry.
Cronos Q4 Financials Are Disappointing: Net Loss Soars By 2725%!
Article By:
Lorimer Wilson
Read
Wednesday, March 6, 2024 4:46 PM EDT
Cronos Q4 were disappointing with revenue down, gross profit down, gross margin down and adjusted EBITDA down as well.
In this article: CRON
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Article By:
Lorimer Wilson
Read
Monday, February 19, 2024 12:05 AM EDT
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex
Article By:
Lorimer Wilson
Read
Sunday, February 18, 2024 6:14 PM EDT
IXHL 's increase was based on the successful completion of an Investigational New Drug meeting with the FDA regarding the development of CannQuit-N for tobacco smoking cessation and relapse control.